SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001069530-23-000021
Filing Date
2023-05-08
Accepted
2023-05-08 16:03:51
Documents
12
Period of Report
2023-05-04
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sava-20230504x8k.htm   iXBRL 8-K 168827
  Complete submission text file 0001069530-23-000021.txt   292392

Data Files

Seq Description Document Type Size
2 EX-101.SCH sava-20230504.xsd EX-101.SCH 2654
3 EX-101.LAB sava-20230504_lab.xml EX-101.LAB 15222
4 EX-101.PRE sava-20230504_pre.xml EX-101.PRE 10839
6 EXTRACTED XBRL INSTANCE DOCUMENT sava-20230504x8k_htm.xml XML 4779
Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29959 | Film No.: 23897658
SIC: 2834 Pharmaceutical Preparations